CBD Clinical Sleep Disorder Case Study
The Permanente Journal from NIH published a CBD Clinical Sleep Disorder Case Study this year (2019). Their summary conclusion: Cannabidiol may hold benefit for anxiety-related disorders. Hence recommending controlled clinical studies.
The study’s objective was to determine whether CBD helps improve sleep and/or anxiety in a clinical population. The design involved clinical application of CBD for anxiety and sleep complaints as an adjunct to usual treatment. And with measurements consisting of sleep and anxiety scores, using validated instruments.
Furthermore, the study saw no evidence of a safety issue that would limit future studies. In this evaluation, CBD appears to be better tolerated than routine psychiatric medications. As a result, CBD displays promise as a tool for reducing anxiety in clinical populations.